Andrographis for COVID-19 and Other Immune Health Applications

In the March 31, 2020 issue of the Journal of Lung, Pulmonary & Respiratory Research, an editorial appeared entitled, “Andrographis paniculata (Green chiretta) may combat COVID-19.”1 The editorial concluded by advising that in-vitro and in-vivo studies are needed before beginning clinical trials on killing effects of A. paniculata on COVID-19. In this article, we will ...